Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 27.2 | 14.0 | 5.3 | 1.0 | 20.3 | 3.3 | 0.7 | 1.3 | 5.0 | 7.7 |
| 65.2% |
| 1.0 |
| 3.7 |
| 27.3% |
| 1.0 |
| 1.0 |
| 100.0% |
| Last 5 | 5 | 27.1 | 10.0 | 5.6 | 0.8 | 16.4 | 2.4 | 0.4 | 1.2 | 3.4 | 5.6 | 60.7% | 0.8 | 3.4 | 23.5% | 0.8 | 0.8 | 100.0% |
| Last 10 | 10 | 28.2 | 13.3 | 6.5 | 1.0 | 20.8 | 1.6 | 0.3 | 1.3 | 3.9 | 6.7 | 58.2% | 1.3 | 4.3 | 30.2% | 1.6 | 1.9 | 84.2% |
| Last 20 | 20 | 29.8 | 14.1 | 5.6 | 1.7 | 21.3 | 1.6 | 0.3 | 1.6 | 3.5 | 6.5 | 52.7% | 1.6 | 4.5 | 34.1% | 2.5 | 3.1 | 79.4% |
| Season | 50 | 31.5 | 14.1 | 5.0 | 1.6 | 20.7 | 1.4 | 0.5 | 1.4 | 3.4 | 6.1 | 55.1% | 1.7 | 4.8 | 36.0% | 2.2 | 2.9 | 76.6% |
high deflections per minute, low usage, low post-ups, low assist rate
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 23.3 | 11 | 5 | 1 | 3 | 0 | 2 | 4 | 8 | 50.0% | 0 | 3 | 0.0% | 3 | 3 | 100.0% | 8.0 |
| 2026-04-10 | PHI @ IND | W | 31.7 | 15 | 7 | 1 | 4 | 1 | 0 | 7 | 16 | 43.8% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 6.0 |
| 2026-04-09 | PHI @ HOU | L | 26.7 | 16 | 4 | 1 | 3 | 1 | 2 | 7 | 10 | 70.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | -21.0 |
| 2026-04-06 | PHI @ SAS | L | 29.4 | 5 | 8 | 0 | 1 | 0 | 1 | 2 | 7 | 28.6% | 0 | 3 | 0.0% | 1 | 1 | 100.0% | -11.0 |
| 2026-04-04 | PHI vs. DET | L | 24.3 | 3 | 4 | 1 | 1 | 0 | 1 | 1 | 4 | 25.0% | 1 | 3 | 33.3% | 0 | 0 | 0.0% | -28.0 |
| 2026-04-03 | PHI vs. MIN | W | 30.1 | 21 | 5 | 1 | 0 | 0 | 0 | 8 | 12 | 66.7% | 4 | 6 | 66.7% | 1 | 1 | 100.0% | 6.0 |
| 2026-04-01 | PHI @ WAS | W | 20.8 | 12 | 4 | 1 | 1 | 0 | 2 | 5 | 10 | 50.0% | 2 | 4 | 50.0% | 0 | 0 | 0.0% | -6.0 |
| 2026-03-30 | PHI @ MIA | L | 30.9 | 11 | 11 | 3 | 0 | 0 | 1 | 5 | 14 | 35.7% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 9.0 |
| 2026-03-28 | PHI @ CHA | W | 27.7 | 9 | 5 | 0 | 1 | 0 | 1 | 3 | 5 | 60.0% | 1 | 3 | 33.3% | 2 | 3 | 66.7% | -1.0 |
| 2026-03-10 | PHI vs. MEM | W | 37.6 | 30 | 12 | 1 | 2 | 1 | 3 | 10 | 24 | 41.7% | 1 | 9 | 11.1% | 9 | 11 | 81.8% | -2.0 |
| 2026-03-09 | PHI @ CLE | L | 13.9 | 6 | 2 | 1 | 0 | 0 | 0 | 1 | 6 | 16.7% | 0 | 3 | 0.0% | 4 | 5 | 80.0% | -8.0 |
| 2026-03-07 | PHI @ ATL | L | 35.9 | 24 | 5 | 4 | 2 | 0 | 5 | 10 | 15 | 66.7% | 3 | 5 | 60.0% | 1 | 3 | 33.3% | -8.0 |
| 2026-03-01 | PHI @ BOS | L | 34.4 | 4 | 4 | 2 | 0 | 0 | 1 | 2 | 10 | 20.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | -7.0 |
| 2026-02-26 | PHI vs. MIA | W | 34.1 | 21 | 8 | 3 | 1 | 0 | 2 | 8 | 13 | 61.5% | 3 | 5 | 60.0% | 2 | 2 | 100.0% | 12.0 |
| 2026-02-24 | PHI @ IND | W | 27.8 | 12 | 4 | 2 | 1 | 0 | 2 | 5 | 8 | 62.5% | 2 | 3 | 66.7% | 0 | 0 | 0.0% | 4.0 |
| 2026-02-22 | PHI @ MIN | W | 35.0 | 18 | 5 | 2 | 4 | 0 | 2 | 5 | 13 | 38.5% | 3 | 7 | 42.9% | 5 | 7 | 71.4% | 23.0 |
| 2026-02-21 | PHI @ NOP | L | 33.3 | 25 | 5 | 2 | 1 | 0 | 0 | 7 | 15 | 46.7% | 4 | 10 | 40.0% | 7 | 8 | 87.5% | -7.0 |
| 2026-02-19 | PHI vs. ATL | L | 32.3 | 17 | 3 | 3 | 3 | 1 | 2 | 4 | 13 | 30.8% | 0 | 3 | 0.0% | 9 | 11 | 81.8% | -2.0 |
| 2026-02-11 | PHI vs. NYK | L | 30.2 | 2 | 7 | 4 | 0 | 1 | 3 | 0 | 6 | 0.0% | 0 | 5 | 0.0% | 2 | 4 | 50.0% | -30.0 |
| 2026-02-09 | PHI @ POR | L | 35.8 | 19 | 4 | 1 | 4 | 2 | 2 | 6 | 13 | 46.2% | 3 | 5 | 60.0% | 4 | 4 | 100.0% | -24.0 |
| 2026-02-07 | PHI @ PHX | W | 38.2 | 18 | 6 | 2 | 2 | 0 | 1 | 6 | 14 | 42.9% | 3 | 7 | 42.9% | 3 | 4 | 75.0% | -3.0 |
| 2026-02-05 | PHI @ LAL | L | 39.8 | 8 | 4 | 3 | 3 | 0 | 0 | 2 | 8 | 25.0% | 0 | 3 | 0.0% | 4 | 4 | 100.0% | 4.0 |
| 2026-02-03 | PHI @ GSW | W | 35.2 | 15 | 6 | 3 | 1 | 0 | 2 | 4 | 12 | 33.3% | 4 | 10 | 40.0% | 3 | 4 | 75.0% | 7.0 |
| 2026-02-02 | PHI @ LAC | W | 34.7 | 15 | 3 | 2 | 1 | 0 | 1 | 6 | 13 | 46.2% | 3 | 6 | 50.0% | 0 | 0 | 0.0% | 11.0 |
| 2026-01-31 | PHI vs. NOP | W | 30.2 | 19 | 10 | 4 | 0 | 0 | 0 | 7 | 13 | 53.8% | 3 | 7 | 42.9% | 2 | 4 | 50.0% | 11.0 |
| 2026-01-29 | PHI vs. SAC | W | 37.3 | 4 | 3 | 0 | 0 | 0 | 1 | 1 | 3 | 33.3% | 0 | 1 | 0.0% | 2 | 2 | 100.0% | 5.0 |
| 2026-01-27 | PHI vs. MIL | W | 22.6 | 7 | 4 | 0 | 1 | 1 | 0 | 3 | 6 | 50.0% | 0 | 2 | 0.0% | 1 | 2 | 50.0% | 1.0 |
| 2026-01-26 | PHI @ CHA | L | 25.1 | 17 | 2 | 0 | 2 | 0 | 2 | 7 | 12 | 58.3% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | -40.0 |
| 2026-01-24 | PHI vs. NYK | L | 37.2 | 14 | 7 | 3 | 2 | 0 | 1 | 5 | 10 | 50.0% | 1 | 4 | 25.0% | 3 | 5 | 60.0% | -3.0 |
| 2026-01-22 | PHI vs. HOU | W | 41.3 | 26 | 4 | 3 | 0 | 1 | 1 | 10 | 14 | 71.4% | 4 | 5 | 80.0% | 2 | 3 | 66.7% | 9.0 |
| 2026-01-20 | PHI vs. PHX | L | 34.0 | 21 | 4 | 1 | 2 | 0 | 2 | 6 | 15 | 40.0% | 5 | 10 | 50.0% | 4 | 6 | 66.7% | 13.0 |
| 2026-01-19 | PHI vs. IND | W | 35.1 | 18 | 1 | 5 | 2 | 1 | 0 | 8 | 14 | 57.1% | 2 | 3 | 66.7% | 0 | 2 | 0.0% | 13.0 |
| 2026-01-16 | PHI vs. CLE | L | 26.1 | 12 | 2 | 1 | 1 | 0 | 1 | 4 | 7 | 57.1% | 2 | 5 | 40.0% | 2 | 2 | 100.0% | -7.0 |
| 2026-01-14 | PHI vs. CLE | L | 26.0 | 7 | 5 | 2 | 0 | 0 | 1 | 2 | 6 | 33.3% | 2 | 5 | 40.0% | 1 | 2 | 50.0% | -19.0 |
| 2026-01-12 | PHI @ TOR | W | 29.5 | 7 | 4 | 0 | 0 | 0 | 2 | 3 | 7 | 42.9% | 1 | 2 | 50.0% | 0 | 0 | 0.0% | 12.0 |
| 2026-01-11 | PHI @ TOR | L | 34.0 | 13 | 5 | 0 | 4 | 3 | 3 | 5 | 10 | 50.0% | 1 | 3 | 33.3% | 2 | 2 | 100.0% | -8.0 |
| 2026-01-09 | PHI @ ORL | W | 14.6 | 0 | 6 | 0 | 0 | 1 | 1 | 0 | 5 | 0.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 9.0 |
| 2026-01-07 | PHI vs. WAS | W | 20.3 | 2 | 3 | 1 | 2 | 0 | 0 | 1 | 4 | 25.0% | 0 | 2 | 0.0% | 0 | 0 | 0.0% | 3.0 |
| 2025-11-14 | PHI @ DET | L | 14.9 | 3 | 1 | 1 | 2 | 0 | 1 | 1 | 5 | 20.0% | 0 | 2 | 0.0% | 1 | 2 | 50.0% | -14.0 |
| 2025-11-11 | PHI vs. BOS | W | 30.8 | 12 | 7 | 0 | 0 | 0 | 2 | 5 | 11 | 45.5% | 0 | 5 | 0.0% | 2 | 2 | 100.0% | -5.0 |
| 2025-11-09 | PHI vs. DET | L | 36.3 | 13 | 5 | 3 | 0 | 1 | 3 | 5 | 13 | 38.5% | 1 | 6 | 16.7% | 2 | 2 | 100.0% | -16.0 |
| 2025-11-08 | PHI vs. TOR | W | 36.9 | 19 | 4 | 1 | 0 | 2 | 2 | 8 | 15 | 53.3% | 1 | 6 | 16.7% | 2 | 3 | 66.7% | 5.0 |
| 2025-11-05 | PHI @ CLE | L | 38.0 | 19 | 3 | 2 | 2 | 0 | 1 | 7 | 16 | 43.8% | 4 | 8 | 50.0% | 1 | 2 | 50.0% | -5.0 |
| 2025-11-04 | PHI @ CHI | L | 32.6 | 18 | 3 | 2 | 2 | 2 | 1 | 7 | 11 | 63.6% | 2 | 4 | 50.0% | 2 | 2 | 100.0% | 2.0 |
| 2025-11-02 | PHI @ BKN | W | 33.3 | 29 | 3 | 0 | 1 | 1 | 2 | 12 | 21 | 57.1% | 3 | 9 | 33.3% | 2 | 2 | 100.0% | 9.0 |
| 2025-10-31 | PHI vs. BOS | L | 40.6 | 17 | 9 | 0 | 2 | 0 | 3 | 6 | 12 | 50.0% | 3 | 7 | 42.9% | 2 | 6 | 33.3% | 5.0 |
| 2025-10-28 | PHI @ WAS | W | 43.8 | 17 | 11 | 1 | 1 | 1 | 1 | 5 | 13 | 38.5% | 3 | 5 | 60.0% | 4 | 5 | 80.0% | 2.0 |
| 2025-10-27 | PHI vs. ORL | W | 39.8 | 25 | 10 | 4 | 1 | 2 | 0 | 9 | 16 | 56.3% | 2 | 6 | 33.3% | 5 | 5 | 100.0% | 10.0 |
| 2025-10-25 | PHI vs. CHA | W | 37.4 | 19 | 1 | 1 | 2 | 0 | 0 | 7 | 10 | 70.0% | 2 | 3 | 66.7% | 3 | 3 | 100.0% | 18.0 |
| 2025-10-22 | PHI @ BOS | W | 33.5 | 10 | 4 | 1 | 0 | 1 | 2 | 2 | 6 | 33.3% | 2 | 6 | 33.3% | 4 | 4 | 100.0% | -8.0 |